Andhra Cements Limited (ACL)

Construction Materials · Cement & Cement Products · NSE · Updated 15 July 2026

₹49.19 ↓ 26.65% (1Y)

🎯 Key Takeaways

Andhra Cements Limited is undergoing a strategic consolidation phase, transitioning from an independent entity to a unified cement group under Sagar Cements Limited following shareholder approval of a merger scheme. The company has faced financial pressure, reporting a net loss of ₹14,080 lakhs in Q4 FY2026 despite revenue growth, and is navigating credit profile improvements amid rising borrowings.
⚠️ 1) The merger with Sagar Cements remains subject to regulatory approvals (NCLT, SEBI, stock exchanges), introducing execution and timeline risk. 2) Pe

Market Cap

₹514

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About ACL 📊 Interactive Charts

📖 The Story

Andhra Cements Limited is undergoing a strategic consolidation phase, transitioning from an independent entity to a unified cement group under Sagar Cements Limited following shareholder approval of a merger scheme. The company has faced financial pressure, reporting a net loss of ₹14,080 lakhs in Q4 FY2026 despite revenue growth, and is navigating credit profile improvements amid rising borrowings. This restructuring marks a pivotal shift in corporate structure and capital allocation strategy.

📰 What's Happening

Shareholders approved all five resolutions at the 87th AGM, including the merger scheme with Sagar Cements Limited and related party transactions totaling up to ₹600 crores. The merger, structured as a share swap (29 shares of Sagar for every 98 shares of ACL), eliminates Andhra Cements as a standalone entity and requires regulatory approvals from NCLT, BSE, NSE, and SEBI. Additionally, India Ratings assigned a stable IND BBB rating to its loan facilities, reducing outstanding debt from INR9,869.70 million to INR9,389.70 million, enhancing borrowing credibility.

Source: Stock Announcements

🔮 Management Outlook & What's Next

Management has not provided explicit forward guidance in the reviewed filings beyond operational updates related to the merger and rating actions. The focus remains on regulatory approvals for the amalgamation and compliance with governance norms. No commentary on profitability timelines, margin improvement, or volume growth was disclosed in the board or rating announcements.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Cement & Cement Products

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
UltraTech Cement Limited	3.38 L Cr	44.1	12.3%	10.8%	0.33
Grasim Industries Limited	2.00 L Cr	21.1	4.9%	4.6%	1.88
Ambuja Cements Limited	1.07 L Cr	23.3	4.6%	7.7%	0.00
SHREE CEMENT LIMITED	90,094	73.6	—	—	—
JK Cement Limited	42,219	58.6	—	—	—
Dalmia Bharat Limited	32,402	57.5	—	—	—
ACC Limited	25,592	12.0	11.0%	10.4%	0.00
The Ramco Cements Limited	21,650	57.2	—	—	—
JSW Cement Limited	16,793	0.0	—	—	—
The India Cements Limited	12,401	-56.7	—	—	—

🔗 Peer Stock Analyses

ULTRACEMCO GRASIM AMBUJACEM SHREECEM JKCEMENT

⚠️ Risk Factors

1) The merger with Sagar Cements remains subject to regulatory approvals (NCLT, SEBI, stock exchanges), introducing execution and timeline risk. 2) Persistent net losses and rising qualified borrowings raise concerns about profitability and debt sustainability. 3) Related party transactions totaling up to ₹600 crores require scrutiny for fairness and long-term strategic rationale. 4) The company’s standalone existence is ending, making post-merger performance dependent on Sagar Cements' integration and governance.

📋 Recent Filings

🧠 Analyst's Read

The company is in a critical phase of structural transformation, with shareholder approval securing the path toward amalgamation under Sagar Cements. Investors should monitor regulatory clearances and integration progress, as near-term financial performance may remain pressured. The credit rating improvement offers some validation of financial discipline, but profitability and capital allocation efficiency post-merger will be key watchpoints.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on ACL

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.

📡 Get AI alerts when ACL files new disclosures

Track ACL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ACL — Free

Free account · 2 AI queries/day